Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in ...

Dr. Mubita joins board certified neurosurgeon Dr. Joshua Anderson and advanced practitioners Caelan Brazee and Tina Stringham. Their practice at 908 N. Howard Ave., Suite 108, is ...

While investigations into the drug are stopping in Alzheimer’s disease, the therapy is now being evaluated in TSC-related ...

Diseases of the nervous system refer to disorders that affect any part of the central nervous system (brain, spinal cord or cranial nerves) or peripheral nervous system. A hallmark of addiction is ...

The development of drugs to treat major diseases of the central nervous system relies in part on the development of novel strategies to cross the blood brain barrier. Michel Khrestchatisky and ...

Audiologist and researcher Dr. Julia Campbell shares her insights into the state of misophonia research and how we may get ...

Research reveals how your daily coffee could be amplifying anxiety symptoms, with genetic factors determining who's most at ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's diseaseSimufilam continued to dem ...

We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer’s ...

Neurodegenerative diseases are a heterogeneous group of disorders that are characterized by the progressive degeneration of the structure and function of the central nervous system or peripheral ...

"In contrast, very few neurons in the central nervous system itself expressed Cdkl," Kanca said ... Borja, Stephanie Bivona, Undiagnosed Diseases Network, Baylor College of Medicine Center for ...

The peripheral nervous system (PNS) is the system of nerves and ganglia outside the brain and spinal cord. The PNS consists ...